NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS
甲状腺功能减退症绵羊胎儿的神经生理学
基本信息
- 批准号:3319777
- 负责人:
- 金额:$ 7.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-09-01 至 1989-08-31
- 项目状态:已结题
- 来源:
- 关键词:5 hydroxytryptophan apomorphine auditory stimulus brain cerebrospinal fluid clonidine dopamine electrodes evoked potentials gas chromatography mass spectrometry gestational age high performance liquid chromatography hypothyroidism neurons neurophysiology neurotransmitters norepinephrine prenatal growth disorder prolactin radioimmunoassay respiratory gas analyzer sensorimotor system serotonin thyroid hormones thyroidectomy
项目摘要
Central nervous system (CNS) dysfunction continues to be a problem in
infants with congenital primary hypothyroidism in spite of the advances
made to allow early diagnosis and treatment through neonatal screening
programs. Many of these CNS abnormalities may be due to the effect of
hypothyroidism in intrauterine life.
The long term objective of this study is to determine the effect of fetal
thyroidectomy on some markers of brain maturation and function using the
ovine fetus as the experimental model. The specific aims of the study are
to prove that (1) thyroidectomy in the ovine fetus causes significant delay
in the maturational pattern of the neurotransmitters norepinephrine (NE),
dopamine (DA), and serotonin (5HT) in specific brain areas, and auditory
and somatosensory evoked responses (ER). (2) Replacement therapy with
thyroid hormones allows the normal maturational progress of NE, DA 5HT and
ER in these areas to resume. (3) If therapy is delayed past a "critical
time period," the normal maturation of NE, DA, 5HT and ER is permanently
arrested. (4) The changes in NE, DA and 5HT caused by ovine fetal
thyroidectomy cause plasma concentrations of growth hormone (GH) and
prolactin (PRL) to be unresponsive to the NE receptor agonist clonidine the
DA receptor agonist apomorphine, and the 5HT precursor 5 hydroxytryptophan
(5HTP).
To achieve these aims, ovine fetuses will undergo thyroidectomy at 85 days
gestation. Control fetuses will undergo sham thyroidectomy. To accomplish
Aim 1: NE, DA and 5HT in cerebrospinal fluid (CSF) and EF will be measured
at set intervals in thyroidectomy and control fetuses. NE, DA and 5HT will
also be measured in specific brain areas at the conclusion of the
experiment. Aim 2: thyroid hormone replacement therapy will be given to
thyroidectomized fetuses beginning at different intervals after
thyroidectomy NE, DA and 5HT in CSF and ER will be measured at set
intervals for the remainder of gestation. At the conclusion of the
experiment, NE, DA and 5HT will be measured in specific brain areas. Aim
3: thyroidectomized fetuses will be studied at more frequent intervals for
a limited segment of gestation with measurement of NE, DA and 5HT in CSF
and in specific brain areas at the end of the experiment. Aim 4: the
response of plasma GH and PRL to clonidine, apomorphine and 5HTP in
thyroidectomized and control fetuses will be tested.
The results of this study will more clearly define the mechanism by which
hypothyroidism interferes with CNS function during fetal development.
中枢神经系统(CNS)功能障碍仍然是一个问题,
先天性原发性甲状腺功能减退症的婴儿,
通过新生儿筛查进行早期诊断和治疗
程序. 许多中枢神经系统异常可能是由于
宫内生活中甲状腺功能减退。
本研究的长期目标是确定胎儿的影响,
甲状腺切除术对脑成熟和功能的一些标志物的影响,
以绵羊胎儿为实验模型。 研究的具体目标是
证明:(1)羊胎甲状腺切除术导致显著延迟
在神经递质去甲肾上腺素(NE)的成熟模式中,
多巴胺(DA)和5-羟色胺(5-HT)在特定的大脑区域,和听觉
和体感诱发反应(ER)。 (2)替代治疗
甲状腺激素允许NE、DA 5 HT和
在这些方面,恢复。 (3)如果治疗延迟超过“临界
在一段时间内,”NE、DA、5 HT和ER的正常成熟是永久性的,
被捕了 (4)绵羊胎仔注射后NE、DA和5-HT的变化
甲状腺切除术会导致血浆生长激素(GH)浓度升高,
催乳素(PRL)对NE受体激动剂可乐定无反应,
DA受体激动剂阿扑吗啡和5-HT前体5-羟色氨酸
(5HTP)。
为了达到这些目的,绵羊胎儿将在85天时接受甲状腺切除术
怀孕 对照胎仔将接受假甲状腺切除术。 完成
目的1:测定脑脊液(CSF)中NE、DA、5-HT及EF
在甲状腺切除术和对照胎儿中以设定的时间间隔。 NE、DA和5 HT将
也可以在特定的大脑区域进行测量,
实验 目的2:甲状腺激素替代治疗将给予
甲状腺切除后不同时间开始的胎仔
将在设定时间点测量CSF和ER中的NE、DA和5 HT
妊娠期剩余时间的间隔。 结束时
实验中,将在特定脑区测量NE、DA和5 HT。 目的
3:将以更频繁的时间间隔研究甲状腺切除胎仔,
有限妊娠期脑脊液NE、DA和5-HT测定
在实验结束时,在特定的大脑区域。 目标4:
可乐定、阿朴吗啡和5-羟色胺对垂体后叶素的反应
将对甲状腺切除胎儿和对照胎儿进行测试。
这项研究的结果将更清楚地界定机制,
甲状腺功能减退在胎儿发育期间干扰CNS功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GAIL E RICHARDS其他文献
GAIL E RICHARDS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GAIL E RICHARDS', 18)}}的其他基金
A PARALLEL GROUP STUDY OF SAFETY AND EFFICACY OF THE LB03002 A NEW SUSTAINED
LB03002 的安全性和有效性的平行小组研究
- 批准号:
7603566 - 财政年份:2007
- 资助金额:
$ 7.48万 - 项目类别:
NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS
甲状腺功能减退症绵羊胎儿的神经生理学
- 批准号:
3319780 - 财政年份:1986
- 资助金额:
$ 7.48万 - 项目类别:
NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS
甲状腺功能减退症绵羊胎儿的神经生理学
- 批准号:
3319782 - 财政年份:1986
- 资助金额:
$ 7.48万 - 项目类别:
NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS
甲状腺功能减退症绵羊胎儿的神经生理学
- 批准号:
3319781 - 财政年份:1986
- 资助金额:
$ 7.48万 - 项目类别:
NEUROTRANSMITTER REGULATION OF GROWTH HORMONE SECRETION
生长激素分泌的神经递质调节
- 批准号:
3884391 - 财政年份:
- 资助金额:
$ 7.48万 - 项目类别:
NEUROTRANSMITTER REGULATION OF GROWTH HORMONE SECRETION
生长激素分泌的神经递质调节
- 批准号:
4700264 - 财政年份:
- 资助金额:
$ 7.48万 - 项目类别:
DIAGNOSITC USE OF LUTEINIZING HORMONE RELEASING HORMONE IN CHILDREN
儿童黄体生成激素释放激素的诊断用途
- 批准号:
4700235 - 财政年份:
- 资助金额:
$ 7.48万 - 项目类别:
CONGENITAL PRIMARY HYPOTHYROIDISM--BRAIN DEVELOPMENT INDICES
先天性原发性甲状腺功能减退症--大脑发育指数
- 批准号:
4700249 - 财政年份:
- 资助金额:
$ 7.48万 - 项目类别:
相似国自然基金
基于多巴胺受体D2亚型为靶标的结构新颖的Apomorphine衍生物的合成及生物活性评估
- 批准号:30672517
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Impairment of insulin signaling in Alzheimer's disease and combined therapy with apomorphine and insulin
阿尔茨海默病中胰岛素信号传导受损以及阿扑吗啡和胰岛素联合治疗
- 批准号:
17K09302 - 财政年份:2017
- 资助金额:
$ 7.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of apomorphine therapy targeting insulin resistance in Alzheimer's disease
针对阿尔茨海默病胰岛素抵抗的阿扑吗啡疗法的开发
- 批准号:
26461274 - 财政年份:2014
- 资助金额:
$ 7.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of apomorphine therapy for Alzheimer disease
阿朴吗啡治疗阿尔茨海默病的分子机制
- 批准号:
23890150 - 财政年份:2011
- 资助金额:
$ 7.48万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Apomorphine-induced modulation of neural activities in the ventrolateral striatum of rat
阿朴吗啡诱导的大鼠腹外侧纹状体神经活动的调节
- 批准号:
22792127 - 财政年份:2010
- 资助金额:
$ 7.48万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of apomorphine therapy for Alzheimer disease
阿朴吗啡治疗阿尔茨海默病的进展
- 批准号:
22590936 - 财政年份:2010
- 资助金额:
$ 7.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAN APOMORPHINE PRODUCE A LONG DURATION RESPONSE
阿扑吗啡可以产生长时间的反应吗
- 批准号:
6465837 - 财政年份:2000
- 资助金额:
$ 7.48万 - 项目类别:
APOMORPHINE CHALLENGE IN SCHIZOPHRENIA & NORMALS
阿扑吗啡对精神分裂症的挑战
- 批准号:
6305710 - 财政年份:1999
- 资助金额:
$ 7.48万 - 项目类别:
APOMORPHINE CHALLENGE IN SCHIZOPHRENIA & NORMALS
阿扑吗啡对精神分裂症的挑战
- 批准号:
6264575 - 财政年份:1998
- 资助金额:
$ 7.48万 - 项目类别:
CAN APOMORPHINE PRODUCE A LONG DURATION RESPONSE
阿扑吗啡可以产生长时间的反应吗
- 批准号:
6116979 - 财政年份:1998
- 资助金额:
$ 7.48万 - 项目类别:
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
舌下含服阿扑吗啡治疗帕金森病——耐受性和疗效
- 批准号:
6116967 - 财政年份:1998
- 资助金额:
$ 7.48万 - 项目类别:














{{item.name}}会员




